Circulating APRIL levels are decreased in diabetic patients. by Adriana Carvalho-Santos (814114)

Subjects:

Knockdown of NG2 by siRNA results in decreased viability and a reduction in PARP levels. by Frank Maus (792209)

Decrease in activity of transcriptional factor NRF2 in MCF-7 cells exposed to gDNA^OX at final concentrations of 50 ng/mL for 2 hours. by Svetlana V. Kostyuk (473354)

Cooperativity decreases with the expression level of CheA. by Stephan Eismann (835052)

Decrease in Rac1 activity in the presence of nectin2alpha:Fc in 3-D cell aggregates. by Khameeka N. Kitt (227731)

Inhibition of Rac1 decreases lamellipodia formation and increases endothelial permeability. by Jerome W. Breslin (548352)

(A) Decreasing CaMKII activity by KN-93 (high-3 µmol/L, low-0.5 µmol/L), AIP (high-10 µmol/L, low-2 µmol/L), or decreasing calmodulin activity by W-7 (high-50 µmol/L, low-20 µmol/L) decreases spontaneous AP firing rate (n = 10 for each drug), cAMP (n = 4 for each drug) and ATP (n = 5 for each drug). by Yael Yaniv (162548)

PTH decreased cell apoptosis in a Flt-3L expanded population. by Flavia Q. Pirih (360515)

Refinement of scrambles, with no USM decreases, no W. by Jedediah M. Singer (10331212)

“…<p>Effects of guided substitutions within scrambled expert-designed proteins, when they are not permitted to decrease USM EC₅₀ predictions or to change amino acids to tryptophan.…”

PLD1 inhibition decreases the c-Myc-dependent dNTP biosynthetic transcriptional program. by Harry E. Taylor (596259)

The decrease in blood flow disrupts CV pruning. by Lin Wen (557398)

Decreased proliferation and increased apoptosis contribute to hypoplasia of <i>Tbx2</i>-deficient lungs. by Timo H-W. Lüdtke (103071)

IC₅₀s data of antimalarials against controls. by Winnie Okore (14139712)

Subjects:

FHL2 silencing decreases osteosarcoma cell growth. by Julia Brun (286504)

Stability scores with refinement, no USM decreases, no W. by Jedediah M. Singer (10331212)

“…<p>Effects of guided and random substitutions within GM designs with a maximum sequence identity to any expert-designed protein of less than 50%, when guided substitutions are not permitted to decrease USM EC₅₀ predictions and neither guided nor random substitutions are allowed to change amino acids to tryptophan.…”

Stability scores with refinement, no USM decreases, no W. by Jedediah M. Singer (10331212)

“…<p>Effects of guided substitutions within expert-designed proteins, when they are not permitted to decrease USM EC₅₀ predictions or to change amino acids to tryptophan.…”

Cytokine dependent decrease in vSMC viability after type I NKT cell activation. by Gijs H. M. van Puijvelde (500345)

Baseline characteristics of women by randomization method^$ (mITT analysis). by Chanel Avenant (409756)

Subjects:

Trial profile. by Chanel Avenant (409756)

Subjects:

Mean percentage changes (95% CI) in total testosterone, SHBG and free testosterone (mITT analysis). by Chanel Avenant (409756)

Subjects: